Dendritic Cells Can Prime Anti-Tumor CD8⁺ T Cell Responses through Major Histocompatibility Complex Cross-Dressing

Scientists demonstrated that MHC-I cross-dressing, an antigen presentation pathway in which dendritic cells acquired and displayed intact tumor-derived peptide:MHC-I molecules, was also important in orchestrating anti-tumor immunity.